v3.26.1
Equity and Earnings per Common Share
 6 Months Ended
Jun. 30, 2026
Equity and Earnings per Common Share [Abstract]  
Equity and Earnings per Common Share
Note 6 — Equity and Earnings per Common Share

Redeemable Preferred Stock


The Company’s charter provides that it has authority to issue up to 100,000,000 shares of preferred stock, $0.01 par value per share, of which 2,781,635 shares are classified as shares of 8.20% Series A Cumulative Redeemable Preferred Stock (the “Series A Preferred Stock”) and 1,604,103 shares are classified as shares of 8.250% Series B Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock (the “Series B Preferred Stock”).


The Company’s Series A Preferred Stock ranks senior to the Company’s common stock with respect to rights to the payment of dividends and the distribution of assets upon the Company’s liquidation, dissolution or winding up. The Series A Preferred Stock has no stated maturity, is not subject to any sinking fund or mandatory redemption and will remain outstanding indefinitely unless repurchased or redeemed by the Company or converted by the holders of the Series A Preferred Stock into the Company’s common stock in connection with certain changes of control. Beginning on August 17, 2022, the Company may, at its option, redeem any or all of the shares of Series A Preferred Stock, at any time or from time to time, for cash at a redemption price equal to $25.00 per share, plus any accumulated and unpaid dividends to, but not including, the date fixed for redemption of the shares of Series A Preferred Stock. The Company did not redeem any shares of Series A Preferred Stock during the three and six-month periods ended June 30, 2026 and the year ended December 31, 2025. If the Company does not exercise its option redemption right, upon certain changes in control, the holders of the Series A Preferred Stock have the right to convert some or all of their shares of Series A Preferred Stock into a number of shares of the Company’s common stock based on a defined formula, subject to a share cap, or alternative consideration. The share cap on each share of Series A Preferred Stock is 2.62881 shares of common stock, subject to certain adjustments. The Company pays cumulative cash dividends at the rate of 8.20% per annum of the $25.00 per share liquidation preference (equivalent to $2.05 per annum per share) on the Series A Preferred Stock, in arrears, on or about the 15th day of January, April, July and October of each year.



The Company’s Series B Preferred Stock ranks senior to the Company’s common stock with respect to rights to the payment of dividends and the distribution of assets upon the Company’s liquidation, dissolution or winding up, and on parity with the Company’s Series A Preferred Stock with respect to rights to the payment of dividends and the distribution of assets upon the Company’s liquidation, dissolution or winding up. The Series B Preferred Stock has no stated maturity, is not subject to any sinking fund or mandatory redemption and will remain outstanding indefinitely unless repurchased or redeemed by the Company or converted by the holders of the Series B Preferred Stock into the Company’s common stock in connection with certain changes of control. The Series B Preferred Stock was not redeemable by the Company prior to April 15, 2024, except under circumstances intended to preserve the Company’s qualification as a REIT for U.S. federal income tax purposes and except upon the occurrence of certain changes of control. Since April 15, 2024, the Company may, at its option, redeem the Series B Preferred Stock, in whole or in part, at any time or from time to time, for cash at a redemption price equal to $25.00 per share, plus any accumulated and unpaid dividends to, but not including, the date fixed for redemption. If the Company does not exercise its rights to redeem the Series B Preferred Stock upon certain changes in control, the holders of the Series B Preferred Stock have the right to convert some or all of their shares of Series B Preferred Stock into a number of shares of the Company’s common stock based on a defined formula, subject to a share cap, or alternative consideration. The share cap on each share of Series B Preferred Stock is 2.68962 shares of common stock, subject to certain adjustments. Holders of shares of Series B Preferred Stock are entitled to receive, when, as and if authorized by the Company’s board of directors and declared by the Company, out of funds legally available for the payment of dividends, cumulative cash dividends. The initial dividend rate for the Series B Preferred Stock from, and including, the date of original issuance to, but excluding, April 15, 2024 was 8.250% of the $25.00 per share liquidation preference per annum (equivalent to $2.0625 per annum per share). During the floating rate period, dividends on the Series B Preferred Stock accumulate at a percentage of the $25.00 liquidation preference equal to an annual floating rate of the three-month CME Term SOFR plus a spread of 5.89261%.


Dividends on the Series A Preferred Stock and Series B Preferred Stock are payable quarterly in arrears on the 15th day of each January, April, July and October, when and as authorized by the Company’s board of directors and declared by the Company.

Common Stock ATM Program


In August 2018, the Company instituted an at-the-market offering program for its common stock (the “Common Stock ATM Program”) of up to $50.0 million of its common stock. In November 2022 and August 2024, the Company entered into amendments to the existing At Market Issuance Sales Agreements, increasing the aggregate offering price to up to an aggregate of $150.0 million of its common stock, of which, approximately $34.6 million was remaining as of June 30, 2026. Under the Common Stock ATM Program, the Company may, but is not obligated to, sell shares of common stock from time to time through one or more selling agents. The Common Stock ATM Program has no set expiration date and may be renewed or terminated by the Company at any time. During the three and six-month period ended June 30, 2026, the Company did not issue or sell any shares pursuant to the Common Stock ATM Program. During the year ended December 31, 2025, the Company issued and sold 4,909,053 shares of common stock under the Common Stock ATM Program. The shares were sold at a weighted average price of $3.00 per share for aggregate gross proceeds of approximately $14.7 million before fees of approximately $293,000.

Common Stock Repurchase Program


In September 2019, the Company instituted a common stock repurchase program that allows for the repurchase of up to an aggregate of $10.0 million of its common stock. Shares of common stock may be repurchased from time to time through privately negotiated transactions or open market transactions, pursuant to a trading plan in accordance with Rules 10b5-1 and 10b-18 under the Securities Exchange Act of 1934, as amended, or the Exchange Act, or by any combination of such methods. The manner, price, number and timing of share repurchases are subject to a variety of factors, including market conditions and applicable SEC rules. The common stock repurchase program does not require the purchase of any minimum number of shares of common stock, and, subject to SEC rules, purchases may be commenced or suspended at any time without prior notice. During the three and six-month periods ended June 30, 2026 and the year ended December 31, 2025, the Company did not repurchase any shares of its common stock pursuant to the common stock repurchase program.

Preferred Stock Repurchase Program


In December 2023, the Company initiated a preferred stock repurchase program that allows for the repurchase of up to an aggregate of $50.0 million of its shares of preferred stock. Shares of preferred stock may be repurchased from time to time through privately negotiated transactions or open market transactions, pursuant to a trading plan in accordance with Rules 10b5-1 under the Exchange Act. The manner, price, number and timing of share repurchases are subject to a variety of factors, including market conditions and applicable SEC rules. The preferred stock repurchase program does not require the purchase of any minimum number of shares of preferred stock, and, subject to SEC rules, purchases may be commenced or suspended at any time without prior notice. During the three and six-month periods ended June 30, 2026 and the year ended December 31, 2025, the Company did not repurchase any shares of its preferred stock pursuant to the preferred stock repurchase program. Shares of preferred stock that are repurchased by the Company cease to be outstanding but remain authorized for future issuance.

Equity Incentive Plan


During 2013, the board of directors approved and the Company adopted the Cherry Hill Mortgage Investment Corporation 2013 Equity Incentive Plan (the “2013 Plan”). The 2013 Plan, which expired by its terms in October 2023, provided for the grant of options to purchase shares of the Company’s common stock, stock awards, stock appreciation rights (“SARs”), performance units, incentive awards and other equity-based awards, including long term incentive plan units of the Operating Partnership (the “LTIP-OP Units”).



In April 2023, the Company’s board of directors adopted the Cherry Hill Mortgage Investment Corporation 2023 Equity Incentive Plan (the “2023 Plan”). The 2023 Plan, which expires by its term in April 2033, permits the Company to provide equity-based compensation in the form of options to purchase shares of the Company’s common stock, stock awards, SARs, performance units, incentive awards and other equity-based awards (including LTIP-OP Units).


The maximum aggregate number of shares of common stock issuable pursuant to the 2023 Plan by the exercise of options and SARs, the grant of stock awards or other equity-based awards (including LTIP-OP Units) and the settlement of incentive awards and performance units is 2,830,000 shares. Other equity-based awards that are LTIP-OP Units will reduce the maximum aggregate number of shares of common stock issuable pursuant to the 2023 Plan on a one-for-one basis—that is, each such LTIP-OP Unit will be treated as an award of common stock; provided, however, for the avoidance of doubt, the conversion of any such LTIP-OP Units at a later date into a share of common stock will not count as an award of common stock under the 2023 Plan for purposes of determining the aggregate limit to avoid any double counting of the same award. In connection with stock splits, dividends, recapitalizations and certain other events, the Company’s board of directors will make equitable adjustments that it deems appropriate in the aggregate number of shares of common stock issuable pursuant to the 2023 Plan and the terms of outstanding awards.
 

If any options or stock appreciation rights terminate, expire or are cancelled, forfeited, exchanged or surrendered without having been exercised or are paid in cash without delivery of common stock or if any stock awards, performance units or other equity-based awards (including LTIP-OP Units) are forfeited, the shares of common stock subject to such awards will again be available for purposes of the 2023 Plan. Shares of common stock tendered or withheld to satisfy the exercise price or for tax withholding are not available for future grants under the 2023 Plan. The Company has elected to account for forfeitures as they occur.


LTIP-OP Units are a special class of partnership interest in the Operating Partnership. LTIP-OP Units may be issued to eligible participants for the performance of services to or for the benefit of the Operating Partnership. Initially, LTIP-OP Units do not have full parity with the Operating Partnership’s common units of limited partnership interest (“OP Units”) with respect to liquidating distributions; however, LTIP-OP Units receive, whether vested or not, the same per-unit distributions as OP Units and are allocated their pro-rata share of the Operating Partnership’s net income or loss. Under the terms of the LTIP-OP Units, the Operating Partnership will revalue its assets upon the occurrence of certain specified events, and any increase in the Operating Partnership’s valuation from the time of grant of the LTIP-OP Units until such event will be allocated first to the holders of LTIP-OP Units to equalize the capital accounts of such holders with the capital accounts of the holders of OP Units. Upon equalization of the capital accounts of the holders of LTIP-OP Units with the other holders of OP Units, the LTIP-OP Units will achieve full parity with OP Units for all purposes, including with respect to liquidating distributions. If such parity is reached, vested LTIP-OP Units may be converted into an equal number of OP Units at any time and, thereafter, enjoy all the rights of OP Units, including redemption rights.


An LTIP-OP Unit and a share of common stock of the Company have substantially the same economic characteristics in as much as they effectively share equally in the net income or loss of the Operating Partnership. Holders of LTIP-OP Units that have reached parity with OP Units have the right to redeem their LTIP-OP Units, subject to certain restrictions. The redemption is required to be satisfied in cash, or at the Company’s option, the Company may purchase the OP Units for common stock, calculated as follows: one share of the Company’s common stock, or cash equal to the fair value of a share of the Company’s common stock at the time of redemption, for each LTIP-OP Unit. When an LTIP-OP Unit holder redeems an OP Unit (as described above), non-controlling interest in the Operating Partnership is reduced and the Company’s equity is increased.


LTIP-OP Units vest ratably over the first three annual anniversaries of the grant date. The fair value of each LTIP-OP Unit was determined based on the closing price of the Company’s common stock on the applicable grant date in all other cases.


On May 30, 2024, the Company granted certain eligible participants of the 2023 Plan other equity-based awards in the form of a total of 181,942 restricted stock units (“RSUs”) under the 2023 Plan. Each granted RSU represents the right to receive one share of common stock. Subject to the terms and conditions of an RSU award agreement and the 2023 Plan, each award of RSUs vests ratably over a three-year period beginning on the one-year anniversary of the grant date of the RSUs. To the extent the RSUs have not otherwise been forfeited or canceled prior to the applicable settlement date, each award recipient will be paid a cash payment on the applicable settlement date equal to the number of shares of common stock delivered multiplied by the total amount of dividend payments made in relation to one share of common stock with respect to record dates occurring during the period between the grant date and the applicable settlement date. On May 30, 2026, 60,041 of these RSU units vested and were settled with a grant of 60,041 units of common stock to the participants. Of the 60,041 shares of common stock granted, 20,253 shares of common stock were withheld by the Company to satisfy tax withholding requirements on the grant. On May 30, 2025, 60,041 of these RSU units vested and were settled with a grant of 60,041 units of common stock to the participants. Of the 60,041 shares of common stock granted, 21,391 shares of common stock were withheld by the Company to satisfy tax withholding requirements on the grant.


On February 10, 2026, the Company granted an individual participant of the 2023 Plan other equity-based awards in the form of a total of 24,414 RSUs under the 2023 Plan. Each granted RSU represents the right to receive one share of common stock. Subject to the terms and conditions of an RSU award agreement and the 2023 Plan, the award of RSUs vests on the one-year anniversary of the grant date of the RSUs. To the extent the RSUs have not otherwise been forfeited or canceled prior to the settlement date, the award recipient will be paid a cash payment on the applicable settlement date equal to the number of shares of common stock delivered multiplied by the total amount of dividend payments made in relation to one share of common stock with respect to the record dates occurring during the period between the grant date and the applicable settlement date.
 

On June 15, 2026, the Company granted an aggregate of 168,068 shares of restricted common stock to the Company’s independent directors (42,017 shares each) subject to the terms and conditions of a restricted stock award agreement and the 2023 Plan. Unless sooner vested in accordance with the terms of the restricted stock award agreement and the 2023 Plan, each independent director’s interest in the shares of common stock covered by the June 15, 2026 stock award become vested and nonforfeitable on the one-year anniversary of the grant date.


Executive Compensation Plan



On April 6, 2026, the board of directors, based upon the recommendation of its compensation committee, approved and adopted the Company’s 2026 Executive Compensation Plan (the “2026 Executive Plan”), effective January 1, 2026. The purpose of the 2026 Executive Plan is to attract, retain and motivate highly-qualified executives to achieve corporate and individual performance objectives and increase stockholder value on an annual and long-term basis. The 2026 Executive Plan provides for annual base salary for the participants as well as compensation opportunities tied to length of service to the Company, individual performance objectives, and Company performance objectives. The Company’s executive compensation program is comprised of short-term incentive compensation (the “STIP”) and long-term equity-based awards (the “LTIP”). The LTIP is comprised of time-based equity awards (the “Time-Based LTIP”) and performance-based equity awards (the “Performance-Based LTIP”). Under the STIP, participating executive officers are eligible to earn annual cash bonuses based on the achievement of specified short-term Company and individual goals. Awards under the STIP are expressed as a dollar amount that is a percentage of each participant’s base salary and are determined based on a combination of Company financial metrics and individual performance objectives, with performance evaluated against defined threshold, target, and maximum levels. Awards under the LTIP are expressed as a dollar amount that is then converted to equity based on a 50/50 split between the Time-Based LTIP and the Performance-Based LTIP, each further calculated into units based on the grant date fair market value. The Time-Based LTIPs vest ratably over a three-year period based solely on length of service. The Performance-Based LTIPs are further split into absolute TSR awards and relative TSR awards and may be earned contingent on defined performance goals tied to Company performance measured over a three-year period, with performance evaluated against specified threshold, target, and maximum levels.



Dividend equivalents on the Performance-Based LTIPs are not paid unless and until the awards are earned. Upon vesting, recipients are entitled to receive cumulative dividends as if the awards had been outstanding since the beginning of the performance period. Dividends or other distributions with respect to the Time-Based LTIPs are paid currently on vested and unvested time-based awards. LTIPs granted under the 2026 Executive Plan are subject to the terms of the 2023 Plan and the Company’s Clawback Policy.


Compensation expense for the STIP awards is accrued over the service period based on the estimated level of achievement of performance conditions. Such estimates are reassessed at each reporting date, and adjustments are recorded as necessary. A portion of the STIP award includes market conditions, the fair value of which is determined using a Monte Carlo simulation model. The model incorporates assumptions for expected volatility, dividend yield, risk-free interest rates, and the correlation of the Company’s performance relative to the peer group. Fair value is remeasured at each quarterly reporting period and adjustments to compensation expense are recorded as necessary.



The Company accounts for share-based compensation in accordance with ASC 718, Compensation—Stock Compensation. The grant-date fair value of equity awards is recognized as compensation expense over the requisite service period. The grant-date fair value of Performance-Based LTIPs which include market conditions is determined using a Monte Carlo simulation model. The model incorporates assumptions for expected volatility, dividend yield, risk-free interest rates, and the correlation of the Company’s stock returns with those of the peer group. The weighted-average grant-date fair value was $2.07 per unit for absolute TSR awards and $3.45 for relative TSR awards. Compensation expense is recognized over the requisite service period regardless of the ultimate level of TSR achieved, provided the requisite service condition is satisfied. Forfeitures are recognized as they occur.
 

The following table sets forth the number of shares of the Company’s common stock as well as LTIP-OP Units and the values thereof (based on the closing prices on the respective dates of grant) granted under the 2013 Plan and the 2023 Plan. As noted above, effective as of June 15, 2023, (the date of the Company’s 2023 annual meeting of stockholders) the 2023 Plan replaced the 2013 Plan. No further awards will be made by the Company under the 2013 Plan, and currently outstanding awards granted under the 2013 Plan will remain effective in accordance with their terms. Except as otherwise indicated, all shares shown in the table below are fully vested.


Equity Incentive Plan Information

 
           LTIP-OP Units               Shares of Common Stock             Restricted Stock Units                     
   
Issued
    
Forfeited/
Redeemed (A)
    
Converted
    
Issued
      
Forfeited (A)
     Withheld (B)     Issued       Forfeited (A)     Settled     Withheld (B)    
Number of Securities
Remaining Available For
Future Issuance Under
Equity Compensation Plans
   
Weighted
Average
Issuance
Price
  
December 31, 2024
    
(663,492
)
    
8,492
      
44,795
      
(283,672
)
      
3,155
       3,229       (181,942 )       -       -       -      
2,434,072
        
Number of securities issued or to be issued upon exercise
    
-
      
-
      
-
      
-
        
-
       -       -         -       -       -      
-
    
$
-
  
March 31, 2025
    
(663,492
)
    
8,492
      
44,795
      
(283,672
)
      
3,155
       3,229       (181,942 )       -       -       -      
2,434,072
          
Number of securities forfeited
    -       14,500       -       -         -       -       -         -       -       -       14,500          
Number of securities redeemed
    
-
      
34,697
      
-
      
-
        
-
       -       -       -       -       -      
34,697
    
$
2.95
  
Number of securities issued or to be issued upon exercise
    -       -       -       (60,041 )       -       21,391       -         -       60,041       -       -          
Number of securities issued or to be issued upon exercise
    -       -       -       (146,520 )       -       -       -         -       -       -       (146,520 )   $ 2.73  
June 30, 2025
    
(663,492
)
    
57,689
      
44,795
      
(490,233
)
      
3,155
       24,620       (181,942 )       -       60,041       -      
2,336,749
          
                                                                                                     
December 31, 2025
    
(663,492
)
    
57,689
      
65,037
      
(510,475
)
      
3,155
       24,620       (181,942 )       -       60,041       -      
2,336,749
          
Number of securities issued or to be issued upon exercise
    
-
      
-
      
-
      
-
        
-
       -       (24,414 ) (C)     -       -       -      
(24,414
)
  
$
2.56
  
March 31, 2026
    
(663,492
)
    
57,689
      
65,037
      
(510,475
)
      
3,155
       24,620       (206,356 )       -       60,041       -      
2,312,335
          
Number of securities issued or to be issued upon exercise
     -       -       -       (60,041 )       -       20,253       -         -       60,041       -       -          
Number of securities issued or to be issued upon exercise
    
-
      
-
      
-
      
-
        
-
       -       (350,380 ) (E)     -       -       -      
(350,380
)
  
$
2.64
  
Number of securities issued or to be issued upon exercise
    
-
      
-
      
-
      
-
        
-
       -       (358,527 ) (F)     -       -       -      
(358,527
)
   $ 2.58  
Number of securities issued or to be issued upon exercise
    -       -       -       (168,068 ) (D)     -       -       -         -       -       -       (168,068 )   $ 2.38  
June 30, 2026
    
(663,492
)
    
57,689
      
65,037
      
(738,584
)
      
3,155
       44,873       (915,263 )       -       120,082       -      
1,435,360
          


(A)
If any award or grant under the 2023 Plan (including LTIP-OP Units) expires, is forfeited or is terminated without having been exercised or is paid in cash without a requirement for the delivery of common stock, then any common stock covered by such lapsed, cancelled, expired, unexercised or cash-settled portion of such award or grant and any forfeited, lapsed, cancelled or expired LTIP-OP Units will be available for the grant or settlement of other awards under the 2023 Plan.

(B)
Any shares of common stock tendered or withheld to satisfy the grant or exercise price or tax withholding obligation pursuant to any award reduces the number of shares of common stock available under the 2023 Plan and those shares will not be available for future grants or awards under the 2023 Plan.

(C)
Subject to forfeiture in certain circumstances prior to February 10, 2027.

(D) Subject to forfeiture in certain circumstances prior to June 15, 2027.

(E) Subject to forfeiture in certain circumstances prior to April 21, 2029.

(F) Subject to satisfaction of defined market-based criteria and subject to forfeiture in certain circumstances prior to December 31, 2028.


The Company recognized share-based compensation expense of approximately $347,000 and $179,000 during the three-month periods ended June 30, 2026 and June 30, 2025, respectively and $543,000 and $357,000 during the six-month periods ended June 30, 2026 and June 30, 2025, respectively. There was approximately $2.5 million of total unrecognized share-based compensation expense as of June 30, 2026, which was related to unvested LTIP-OP Units, directors compensation paid in stock subject to forfeiture and unvested RSUs. This unrecognized share-based compensation expense is expected to be recognized ratably over the remaining vesting period of up to three years. The aggregate expense related to the LTIP-OP Unit grants and the RSUs is presented within “Compensation and benefits” in the Company’s consolidated statements of income (loss).

Non-Controlling Interests in Operating Partnership


Non-controlling interests in the Operating Partnership in the accompanying consolidated financial statements relate to LTIP-OP Units and OP Units issued upon conversion of LTIP-OP Units, in either case, held by parties other than the Company.


As of June 30, 2026, the non-controlling interest holders in the Operating Partnership owned 531,712 LTIP-OP Units, or approximately 1.45% of the units of the Operating Partnership. Pursuant to ASC 810, Consolidation, changes in a parent’s ownership interest (and transactions with non-controlling interest unit holders in the Operating Partnership) while the parent retains its controlling interest in its subsidiary should be accounted for as equity transactions. The carrying amount of the non-controlling interest will be adjusted to reflect the change in its ownership interest in the subsidiary, with the offset to equity attributable to the Company.

Earnings per Common Share


The Company is required to present both basic and diluted earnings per common share (“EPS”). Basic EPS is calculated by dividing net income applicable to common stockholders by the weighted average number of shares of common stock outstanding during each period. Diluted EPS is calculated by dividing net income applicable to common stockholders by the weighted average number of shares of common stock outstanding plus the additional dilutive effect of common stock equivalents during each period. In accordance with ASC 260, Earnings Per Share, if there is a loss from continuing operations, the common stock equivalents are deemed anti-dilutive and earnings (loss) per share is calculated excluding the potential common shares.



The following table presents basic and diluted earnings per share of common stock for the periods indicated (dollars in thousands, except per share data):

Earnings per Common Share Information

 
  
Three Months Ended June 30,
    
Six Months Ended June 30,
  
 
  
2026
    
2025
    
2026
    
2025
  
Numerator:
                        
Net income (loss)
  
$
3,794
    
$
1,561
    
$
4,223
    
$
(5,431
)
Net (income) loss allocated to noncontrolling interests in Operating Partnership
    
(55
)
    
(34
)
    
(61
)
    
99
  
Dividends on preferred stock
    
(2,403
)
    
(2,462
)
    
(4,794
)
    
(4,916
)
Gain (loss) on repurchase and retirement of preferred stock
     -       -       -       -  
Net income allocated to participating securities
     -       -       -       -  
Numerator for basic EPS - net income (loss) applicable to common stockholders (A)
   $ 1,336   $ (935 )   $ (632 )   $ (10,248 )
Effect of dilutive securities:
                                
Add back net income allocated to participating securities
     -       -       -       -  
Numerator for diluted EPS - net income (loss) applicable to common stockholders after assumed conversion (C)
   $ 1,336   $ (935 )   $ (632 )   $ (10,248 )
Denominator:
                                
Denominator for basic EPS - weighted average common shares (B)
    
36,605,698
       33,199,712       36,599,393       32,449,353  
Effect of dilutive securities:
                                
Participating restricted stock awards
     121,188       -       -       -  
Participating restricted stock units
    -       -       -       -  
Non-participating restricted stock units
     12,513       -       -       -  
Non-participating performance stock units
     -
       -        -
       -  
Denominator for diluted EPS - adjusted weighted average common shares (D)
     36,739,399       33,199,712       36,599,393       32,449,353  
Basic and Diluted EPS:
                                
Basic (A/B)
  
$
0.04
 
$
(0.03
)
  
$
(0.02
)
  
$
(0.32
)
Diluted (C/D)
  
$
0.04
 
$
(0.03
)
  
$
(0.02
)
  
$
(0.32
)


The computation of diluted EPS for the six-month period ended June 30, 2026 excludes 1,528,829 of potentially dilutive restricted stock units and restricted stock awards because their effect would have been anti-dilutive.